Imunon, Inc.

General ticker "IMNN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $14.8M (TTM average)

Imunon, Inc. does not follow the US Stock Market performance with the rate: -28.7%.

Estimated limits based on current volatility of 2.6%: low 3.76$, high 3.96$

Factors to consider:

  • Total employees count: 31 as of 2022
  • Current price 41.0% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [6.36$, 19.30$]
  • 2025-12-31 to 2026-12-31 estimated range: [3.70$, 11.86$]

Financial Metrics affecting the IMNN estimates:

  • Negative: with PPE of -7.8 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -171.44 <= 0.33
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: negative Industry operating cash flow (median)
  • Positive: 41.86 < Shareholder equity ratio, % of 43.68 <= 63.39
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: Investing cash flow per share per price, % of 89.37 > -0.66

Similar symbols

Short-term IMNN quotes

Long-term IMNN plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.50MM $0.00MM $0.00MM
Operating Expenses $25.42MM $21.03MM $19.13MM
Operating Income $-24.92MM $-21.03MM $-19.13MM
Non-Operating Income $-12.54MM $0.24MM $0.51MM
Interest Expense $5.03MM $0.20MM $0.00MM
R&D Expense $11.73MM $11.29MM $11.64MM
Income(Loss) $-37.47MM $-20.80MM $-18.62MM
Taxes $-1.57MM $-1.28MM $0.00MM
Profit(Loss)* $-35.90MM $-19.51MM $-18.62MM
Stockholders Equity $29.33MM $13.39MM $4.24MM
Assets $43.98MM $21.92MM $9.72MM
Operating Cash Flow $-23.10MM $-19.02MM $-18.85MM
Capital expenditure $0.27MM $0.45MM $0.03MM
Investing Cash Flow $8.28MM $11.01MM $9.83MM
Financing Cash Flow $6.72MM $-3.64MM $9.06MM
Earnings Per Share** $-65.55 $-28.14 $-21.10

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.